MCF-7 and T-47D cells expressed low but detectable IGFBP-3 (intracellular and extracellular), whereas both MDA-MB-231 and MDA-MB-468 cells had significantly higher levels of IGFBP-3 when compared to ERα positive breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.